Hypertension Diagnostics Valuation

Hypertension Diagnostics Investor Information

The company recorded a loss per share of 0.0. Hypertension Diagnostics had not issued any dividends in recent years. Based on the key indicators related to Hypertension Diagnostics' liquidity, profitability, solvency, and operating efficiency, Hypertension Diagnostics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Hypertension Diagnostics Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Hypertension signifies not a very effective usage of assets in March.

Hypertension Diagnostics Profitability Analysis

The company reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.